Uniform Bio Inc.
Summary
Uniform Bio Inc. raised $65.0M in a Regulation D private placement on June 2, 2026, with backing from top-tier venture firms Flagship Pioneering and ARCH Venture Partners. The filing is an initial Form D, indicating a fresh capital raise in the technology venture sector. This substantial amount for a private company signals strong investor confidence and potential for significant growth.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Full Analysis
Executive Summary
Uniform Bio Inc. raised $65.0M in a Regulation D private placement on June 2, 2026, with backing from top-tier venture firms Flagship Pioneering and ARCH Venture Partners. The filing is an initial Form D, indicating a fresh capital raise in the technology venture sector. This substantial amount for a private company signals strong investor confidence and potential for significant growth.
Investor Edge
Sophisticated investors should monitor for a subsequent Form D/A (amendment) which could reveal a larger round or changed terms, and watch for any public disclosures of partnerships or clinical milestones that often follow such raises.
Sector capital positioning
The $65.0M raise in Technology Venture underscores robust capital flow into deep-tech or biotech-adjacent startups, likely targeting high-risk, high-reward innovations. The involvement of Flagship and ARCH suggests a focus on platform technologies or novel therapeutics.
Convergence Signals
No public signals (patents, contracts, legislation) are evident from the filing data. The absence of a ticker and the private nature of the company limit convergence insights.
Key Takeaways
- Uniform Bio Inc. raised $65.0M in a private placement, a significant sum for a pre-IPO company.
- Backed by Flagship Pioneering and ARCH Venture Partners, indicating high-caliber institutional support.
- Initial Form D suggests this is a new raise, not an amendment, implying fresh capital injection.
Risk Indicators & Flags
No red flags identified: the filing is an initial Form D (not an amendment), the amount is consistent with a large venture round, and the sector is typical for such raises. However, the state is listed as 'Unknown,' which may indicate incomplete disclosure or a non-U.S. entity, warranting further due diligence.
Verification & References
Verify filing details via SEC EDGAR using accession number 000213678126000001. Confirm company name (Uniform Bio Inc.), CIK (0002136781), and capital amount ($65.0M) directly from the Form D filing.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Matthias Therapeutics, LLC
Dare Bioscience, Inc.
Anika Therapeutics, Inc.
DEF 14A - Outlook Therapeutics, Inc.
Strategy Inc
Outlook Therapeutics, Inc.
Pacira BioSciences, Inc.
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Declaring a National Emergency to Secure the United States Bulk-Power System
This executive order declares a national emergency to restrict foreign-produced bulk-power system electric equipment that poses national security risks, prohibiting new transactions involving equipment from covered foreign entities and allowing the Secretary of Energy to impose conditions on existing equipment. It directs the Secretary of Energy, in coordination with multiple agencies, to identify, mitigate, and potentially replace risky equipment, and establishes a pre-qualification list for approved vendors.
The National Space Transportation Policy
This memorandum directs multiple agencies to expand and modernize U.S. space launch and reentry infrastructure to support over 1,000 launches annually by 2030, expedite permitting and environmental reviews, develop new federal reentry sites, and strengthen the space transportation industrial base. It mandates range scheduling transparency, spectrum reliability, and workforce development, with specific reports and plans due within 90 to 240 days.
Adjusting Imports of Unmanned Aircraft Systems and Unmanned Aircraft Systems Components into the United States
This proclamation imposes a 100% ad valorem tariff on imports of unmanned aircraft systems (UAS) over 25 kg, those with thermal imagers, docking stations, and certain components, and a 25% tariff on UAS under 25 kg and other components, citing national security under Section 232 of the Trade Expansion Act. It also authorizes the Department of Commerce to establish an onshoring program offering preferential tariff treatment for companies that build new U.S. manufacturing facilities for UAS and components.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →